Filing Details
- Accession Number:
- 0001140361-12-025509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-15 13:00:00
- Reporting Period:
- 2012-05-15
- Filing Date:
- 2012-05-15
- Accepted Time:
- 2012-05-15 17:07:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
69499 | Mylan Inc. | MYL | Pharmaceutical Preparations (2834) | 251211621 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197543 | J Robert Coury | 1500 Corporate Drive Canonsburg PA 15317 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-15 | 91,875 | $12.38 | 1,032,369 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-05-15 | 91,875 | $21.30 | 940,494 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option Right to Buy | Acquisiton | 2012-05-15 | 91,875 | $0.00 | 91,875 | $12.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-07-22 | 2012-07-22 | No | 4 | M | Direct |
Footnotes
- As disclosed in the Company's Form 10-Q for the quarter ended September 30, 2011, Mr. Coury's stock options were among those held by directors that were set to expire in 2012.
- The reporting person's indirect ownership through 401(k) holdings as of May 15, 2012 was 4,957.
- Represents the weighted price of the reporting person's disposition of 91,875 shares in transactions ranging from $21.13 to $21.49.
- This option exercise and the related sale were executed pursuant to a 10b5-1 trading plan dated December 14, 2011.